ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,393.80
0.85%
S&P ASX All Technology
3,840.60
-1.02%
Brent Oil
74.65
0.00%
US Dollar vs AUD
1.53846
0.00%
Bitcoin
97,968.37
0.19%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Novavax Inc (NVAX)

  7. Novavax Inc (NVAX) News

NVAX

Novavax (NVAX)

Novavax Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NVAX
DateTimeSourceHeadlineSymbolCompany
15/11/202423:47PR Newswire (US)Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)NASDAQ:NVAXNovavax Inc
14/11/202408:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
14/11/202400:00PR Newswire (US)Novavax to Participate in Jefferies London Healthcare ConferenceNASDAQ:NVAXNovavax Inc
13/11/202408:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVAXNovavax Inc
13/11/202403:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
13/11/202400:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
13/11/202400:02PR Newswire (US)Novavax Reports Third Quarter 2024 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
12/11/202400:30PR Newswire (US)U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 TrialNASDAQ:NVAXNovavax Inc
06/11/202409:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
05/11/202408:30PR Newswire (US)Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024NASDAQ:NVAXNovavax Inc
04/11/202422:00PR Newswire (US)Åsa Manelius Named Managing Director of Novavax AB SiteNASDAQ:NVAXNovavax Inc
16/10/202423:14PR Newswire (US)Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 TrialNASDAQ:NVAXNovavax Inc
16/10/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
09/10/202422:00PR Newswire (US)Novavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EUNASDAQ:NVAXNovavax Inc
25/09/202422:00PR Newswire (US)Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & DevelopmentNASDAQ:NVAXNovavax Inc
19/09/202406:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NVAXNovavax Inc
13/09/202423:25PR Newswire (US)Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S.NASDAQ:NVAXNovavax Inc
04/09/202423:25PR Newswire (US)Novavax to Participate in Upcoming September ConferencesNASDAQ:NVAXNovavax Inc
31/08/202406:19PR Newswire (US)Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.NASDAQ:NVAXNovavax Inc
31/08/202405:46PR Newswire (US)Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.NASDAQ:NVAXNovavax Inc
22/08/202406:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
21/08/202407:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
09/08/202406:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NVAXNovavax Inc
08/08/202422:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
08/08/202422:02PR Newswire (US)Novavax Reports Second Quarter 2024 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
08/08/202421:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVAXNovavax Inc
08/08/202419:55IH Market NewsU.S. Index Futures Drop, Signaling Ongoing Market Volatility; Oil Prices StallNASDAQ:NVAXNovavax Inc
01/08/202423:25PR Newswire (US)Novavax to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Operational Highlights on August 8, 2024NASDAQ:NVAXNovavax Inc
31/07/202419:55IH Market NewsASML Rises 7% on Export Waiver; Intel Plans Layoffs, HSBC $3B Buyback Announced, and MoreNASDAQ:NVAXNovavax Inc
02/07/202422:30PR Newswire (Canada)Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 VaccineNASDAQ:NVAXNovavax Inc
 Showing the most relevant articles for your search:NASDAQ:NVAX

Your Recent History

COIN
ADAUSD
Cardano
FX
GBPAUD
Sterling vs AUD
NASDAQ
AMZN
Amazon.com
ASX
AMP
AMP
ASX
WES
Wesfarmers
ASX
ANZ
Australia And New Zealan...
NYSE
VZ
Verizon Communications
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
FMG
Fortescue
ASX
WDC
Westfield
FTSE
UKX
FTSE 100
NASDAQ
AAPL
Apple
COIN
DOGEUSD
Dogecoin
NASDAQ
TSLA
Tesla
ASX
WOW
Woolworths
ASX
MQG
Macquarie
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved